In addition, PHF6 over-expressing myeloid leukemia cells were more sensitive to NF-κB inhibitor (BAY11-7082) than the other cells, indicating that NF-κB signaling pathways might be a new suppressive target for treatment of myeloid leukemia patients with PHF6 high expression. The gene discussed is PHF6; the disease is myeloid leukemia.